Last reviewed · How we verify
Investigational HIV vaccine dose A — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
Investigational HIV vaccine dose A (Investigational HIV vaccine dose A) — Institut Pasteur.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Investigational HIV vaccine dose A TARGET | Investigational HIV vaccine dose A | Institut Pasteur | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Investigational HIV vaccine dose A CI watch — RSS
- Investigational HIV vaccine dose A CI watch — Atom
- Investigational HIV vaccine dose A CI watch — JSON
- Investigational HIV vaccine dose A alone — RSS
Cite this brief
Drug Landscape (2026). Investigational HIV vaccine dose A — Competitive Intelligence Brief. https://druglandscape.com/ci/investigational-hiv-vaccine-dose-a. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab